approval · primary record
BLINATUMOMAB
FDA · BLA · 2025-10-21
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-10-21 |
| Brand | BLINCYTO |
| Sponsor | AMGEN |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:38:34.937Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:BLINATUMOMAB:2025-10-21
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Blinatumomab · compound